Bioverativ Q3 FY17: revenue $291.6M

Key figures from this report

These are the numbers Bioverativ reported for Q3 FY17, the quarter ended Sep 30, 2017, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

1. Revenue$291.6MNo year-earlier figure tagged10-Q income statement, on EDGAR
2. Net income$67.9MNo year-earlier figure tagged10-Q income statement, on EDGAR
3. Cash and cash equivalents$224.1MNo year-earlier figure tagged10-Q balance sheet, on EDGAR
4. Cash from operations$136.2MNo year-earlier figure tagged10-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters